June 17, 2021 07:32 AM EDTUpdated 09:55 AM

Covid-19 roundup: Pfizer says Xeljanz reduced death and lung failure in hospitalized Covid-19 patients; US halts distribution of Eli Lilly’s mAb combo to Rhode Island due to variants

In addition to its ultra-effective mRNA vaccine, Pfizer believes it could have another weapon to fight the Covid-19 pandemic.

The company

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Pfiz­er says Xel­janz re­duced death and lung fail­ure in hos­pi­tal­ized Covid-19 pa­tients; US halts dis­tri­b­u­tion of Eli Lil­ly’s mAb com­bo to Rhode Is­land due to vari­ants